Studies on pyrimidine biosynthesis in the granulocytes of patients receiving gold therapy for rheumatoid arthritis.
D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D001221:Aspartate Carbamoyltransferase / Q000037:antagonists & inhibitors; D002452:Cell Count; D005260:Female; D006052:Gold Sodium Thiomalate / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007958:Leukocyte Count; D007962:Leukocytes / Q000201:enzymology / Q000378:metabolism*; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008297:Male; D008875:Middle Aged; D009504:Neutrophils; D010430:Pentosyltransferases / Q000037:antagonists & inhibitors; D010770:Phosphotransferases / Q000037:antagonists & inhibitors; D011742:Pyrimidine Nucleotides / Q000096:biosynthesis*
D011742:Pyrimidine Nucleotides; D006052:Gold Sodium Thiomalate; D001221:Aspartate Carbamoyltransferase; D010430:Pentosyltransferases; D010770:Phosphotransferases